Your browser doesn't support javascript.
loading
Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processing.
Wagner, Timo; Dieckmann, Marco; Jaeger, Sebastian; Weggen, Sascha; Pietrzik, Claus U.
Afiliación
  • Wagner T; Institute of Pathobiochemistry, University Medical Centre of the Johannes Gutenberg-University, Duesbergweg 6, 55099 Mainz, Germany.
  • Dieckmann M; Institute of Pathobiochemistry, University Medical Centre of the Johannes Gutenberg-University, Duesbergweg 6, 55099 Mainz, Germany; Department of Molecular Genetics, University of Texas Southwestern Medical Centre at Dallas, Dallas, TX, United States of America.
  • Jaeger S; Institute of Pathobiochemistry, University Medical Centre of the Johannes Gutenberg-University, Duesbergweg 6, 55099 Mainz, Germany.
  • Weggen S; Department of Neuropathology, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Pietrzik CU; Institute of Pathobiochemistry, University Medical Centre of the Johannes Gutenberg-University, Duesbergweg 6, 55099 Mainz, Germany. Electronic address: pietrzik@uni-mainz.de.
Exp Cell Res ; 319(13): 1956-1972, 2013 Aug 01.
Article en En | MEDLINE | ID: mdl-23701949
ABSTRACT
We identified syntaxin 5 (Stx5), a protein involved in intracellular vesicle trafficking, as a novel interaction partner of the very low density lipoprotein (VLDL)-receptor (VLDL-R), a member of the LDL-receptor family. In addition, we investigated the effect of Stx5 on VLDL-R maturation, trafficking and processing. Here, we demonstrated mutual association of both proteins using several in vitro approaches. Furthermore, we detected a special maturation phenotype of VLDL-R resulting from Stx5 overexpression. We found that Stx5 prevented advanced Golgi-maturation of VLDL-R, but did not cause accumulation of the immature protein in ER, ER to Golgi compartments, or cis-Golgi ribbon, the main expression sites of Stx5. Rather more, abundantly present Stx5 was capable of translocating ER-/N-glycosylated VLDL-R to the plasma membrane, and thus was insensitive to BFA treatment and low temperature. Furthermore, abundant presence of Stx5 significantly interfered with VLDL-R reaching the trans-Golgi network. Based on our findings, we postulate that Stx5 can directly bind to the C-terminal domain of VLDL-R, thereby influencing the receptor's glycosylation, trafficking and processing characteristics. Resulting from that, we further suggest that Stx5 might play a role in modulating VLDL-R physiology by participating in an abrasively described or completely novel Golgi-bypass pathway.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de LDL / Proteínas Qa-SNARE Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Exp Cell Res Año: 2013 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de LDL / Proteínas Qa-SNARE Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Exp Cell Res Año: 2013 Tipo del documento: Article País de afiliación: Alemania